17:27 - 20.02.2026
February 20, Fineko/abc.az. Johnson & Johnson (U.S.) is considering the sale of its orthopedic division, DePuy Synthes, ABC.AZ informs, referring to Bloomberg’s sources.
The asset has already attracted investor interest and can be valued at more than $20 bn.
The company previously planned to separate DePuy Synthes into a separate structure to increase business efficiency and value. The division manufactures hip and knee implants and generated revenue of $9.3 bn last year. Negotiations with potential buyers may begin in the coming weeks, but discussions on the deal are still at an early stage.
